Amedisys (NASDAQ:AMED) Shares Gap Up – What’s Next?

Amedisys, Inc. (NASDAQ:AMED)’s share price gapped up before the market opened on Friday . The stock had previously closed at $85.95, but opened at $89.50. Amedisys shares last traded at $89.46, with a volume of 536,164 shares.

Amedisys Price Performance

The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.05. The business has a 50 day simple moving average of $90.45 and a 200-day simple moving average of $94.43. The company has a market capitalization of $2.95 billion, a P/E ratio of 35.70, a PEG ratio of 1.84 and a beta of 0.73.

Amedisys (NASDAQ:AMED) last issued its quarterly earnings results on Wednesday, November 6th. The health services provider reported $1.00 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.19 by ($0.19). The firm had revenue of $587.67 million for the quarter, compared to analyst estimates of $586.75 million. Amedisys had a net margin of 3.57% and a return on equity of 12.20%. The firm’s revenue for the quarter was up 5.7% compared to the same quarter last year. During the same quarter last year, the business posted $0.98 earnings per share. Analysts predict that Amedisys, Inc. will post 4.45 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of AMED. Polar Asset Management Partners Inc. bought a new stake in shares of Amedisys during the 3rd quarter worth $28,953,000. SG Americas Securities LLC lifted its holdings in shares of Amedisys by 413.4% during the 3rd quarter. SG Americas Securities LLC now owns 196,713 shares of the health services provider’s stock worth $18,985,000 after acquiring an additional 158,398 shares during the period. Verition Fund Management LLC boosted its holdings in Amedisys by 608.1% during the third quarter. Verition Fund Management LLC now owns 114,774 shares of the health services provider’s stock valued at $11,077,000 after purchasing an additional 98,565 shares in the last quarter. Westchester Capital Management LLC grew its position in Amedisys by 9.5% in the third quarter. Westchester Capital Management LLC now owns 1,118,802 shares of the health services provider’s stock valued at $107,976,000 after acquiring an additional 97,476 shares during the period. Finally, Highbridge Capital Management LLC increased its position in shares of Amedisys by 34.7% during the 2nd quarter. Highbridge Capital Management LLC now owns 323,200 shares of the health services provider’s stock worth $29,670,000 after purchasing an additional 83,200 shares in the last quarter. 94.36% of the stock is owned by institutional investors and hedge funds.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.